Back to search
FDAFDA · Food and drugs·Recall number D-1412-2014

Bystolic (nebivolol) tablets, 20 mg/tablet. 7 Tablet Professional Sample Bottle, Rx Only. Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, Missouri 63045. NDC 0456-1420-07.

Published July 9, 2014 · Recall initiated: June 19, 2014

Summary

FDA records drug Class II recall D-1412-2014, published July 9, 2014 and initiated June 19, 2014. Recalling firm: Forest Pharmaceuticals Inc; Status: Terminated; Reported quantity: 92,544 Bottles; Lot: Lot # A308879, Expiry: 09/2015. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications: Drug failed stage III dissolution testing.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Forest Pharmaceuticals Inc
Distributor
Nationwide including Puerto Rico.
Lot
Lot # A308879, Expiry: 09/2015
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Bystolic (nebivolol) tablets, 20 mg/tablet. 7 Tablet Professional Sample Bottle, Rx Only. Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, Missouri 63045. NDC 0456-1420-07. recalled?

Yes. FDA published recall D-1412-2014 on July 9, 2014. Reported hazard: Failed Dissolution Specifications: Drug failed stage III dissolution testing.

What should I do if I have this product?

Voluntary: Firm initiated · Letter